Burning Rock Biotech Limited
Burning Rock Biotech Limited (BNR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bnr · stock forecast · 3 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 3 Wall Street analysts in the past 3 months
Buy
3 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $9.07
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $8.62 | ↓ 5.00% |
1-day model range: $8.34–$8.89. Peak: $8.89 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · BNR · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2021-07-14 | CICC | Maintains | Outperform→Outperform |
| 2020-07-13 | B of A Securities | Maintains | Buy→Buy |
| 2020-07-07 | Cowen & Co. | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Burning Rock Biotech Limited (BNR) stock. Of the recent 3 rating actions, 0 were upgrades and 0 were downgrades. 3 analysts currently cover BNR.
Analyst Recommendation Trends
BNR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$503M
↓ 25.6% YoY
Revenue Next Year
$529M
↑ 5.2% YoY
EPS This Year
$-70.03
EPS Next Year
$-83.06
↑ 18.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast BNR EPS of $-70.03 for the current fiscal year, based on estimates from 1 analysts. The BNR revenue forecast is $503M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BNR stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BNR price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The BNR short-term stock prediction for tomorrow is $8.62 (-5.00%).
Burning Rock Biotech Limited trades on NASDAQ under the ticker BNR. The BNR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
BNR forecast · 8 questionsAccording to 3 Wall Street analysts, the average 12-month BNR price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $9.07.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.